Table 1.
Peptide | Minimal Inhibitory Concentration | Active biofilm concentration | Active against | Reference |
---|---|---|---|---|
AS10 | 50 μMa | 0.22 μMb | C. albicans | [16] |
KT2 and RT2 | 5 – 18 μM | 1 μMc | E. coli | [13] |
SB056 and derivatives | 10 – >40 μM | 5–20 μMd | S. epidermidis, P. aeruginosa | [14] |
Cyclic lipopetide 3 | 22 –55 μM | 4 μMc | S. aureus, P. aeruginosa | [15] |
LL-37 and derivatives | 32 μg/ml | 1–16 μg/mld | S. aureus, E. coli | [9,31] |
(IDR-)1018 | 8 – 128 μg/ml | 2–8 μg/mlb | A. baumannii, E. coli, K. pneumoniae, P. aeruginosa, S. enterica, S. aureus | [10] |
DJK-5 | 1.6 – 16 μg/ml | 0.8 – 4 μg/mlb | as for IDR-1018 | [11] |
DJK-6 | 4 – 16 μg/ml | 0.5 – 8 μg/mlb | as for IDR-1018 | [11] |
Minimal fungicidal concentration
Minimal biofilm inhibitory concentration
Active concentration in flow cells
Concentrations showing biofilm inhibition